34 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Liquidia Technologies, Inc. LQDA shares climbed 32.4% to $4.6603 after Wedbush maintained an Outperform rating on the stock.
• NewLink Genetics Corporation NLNK gained 34.6% to $3.1350 on above-average price action. The company announced an exclusive worldwide license with Ellipses Pharma on December 23rd.
• Acorda Therapeutics, Inc. ACOR shares rose 23% to $2.36.
• Clearside Biomedical, Inc. CLSD surged 19.6% to $3.66.
• SilverCrest Metals Inc. SILV gained 19% to $7.88.
• Tetraphase Pharmaceuticals, Inc. TTPH shares jumped 18.1% to $2.8343.
• Can-Fite BioPharma Ltd. CANF gained 16.8% to $3.48 after the company reported that strategic partnership with Univo to develop cannabinoid-based products is ongoing.
• McDermott International, Inc. MDR surged 16.7% to $1.2370.
• Proteostasis Therapeutics, Inc. PTI rose 16.4% to $2.6183 after climbing 51.01% on Tuesday.
• Acasti Pharma Inc. ACST gained 15.4% to $2.5502 on a rebound after the stock price dropped on December 23rd after releasing news surrounding its TRILOGY 1 trial.
• Novan, Inc. NOVN shares rose 14.6% to $3.4159.
• SilverSun Technologies, Inc. SSNT shares gained 13.8% to $4.38.
• Soleno Therapeutics, Inc. SLNO surged 12.5% to $3.14.
• Rite Aid Corporation RAD gained 12.4% to $18.14.
• Technical Communications Corporation TCCO shares gained 12.3% to $5.29 after rising 10.3% on Tuesday.
• Equinox Gold Corp. EQX gained 11.5% to $7.96.
• Aldeyra Therapeutics, Inc. ALDX shares climbed 9.8% to $6.24.
• Synlogic, Inc. SYBX gained 9.6% to $2.63.
• BioDelivery Sciences International, Inc. BDSI shares rose 7.5% to $7.09.
• Immunomedics, Inc. IMMU rose 6.7% to $21.86 after the company announced the FDA accepted for filing the company's BLA seeking accelerated approval of sacituzumab govitecan to treat metastatic triple-negative breast cancer.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Spring Bank Pharmaceuticals, Inc. SBPH shares fell 57.6% to $1.5326 after the company reported that it has stopped dosing of inarigivir patients in Phase 2 program.
• Spectrum Pharmaceuticals, Inc. SPPI shares dipped 56.1% to $3.8450 after the company reported that its pre-specified primary endpoint in the Phase 2 Trial of Poziotinib in the previously treated NSCLC was not met in the Cohort 1.
• QIAGEN N.V. QGEN fell 22.4% to $32.18 after the company announced it would not be acquired and it will stay a stand-alone business. Bank of America also reinstated its Underperform rating on the stock and announced a price target of $28 per share.
• Hexo Corp HEXO dropped 20.7% to $1.5550 after the company reported $25 million offering of 14.97 million shares at $1.67 per share.
• Microbot Medical Inc. MBOT fell 17% to $13.52 after climbing 61.03% on Tuesday. Microbot Medical, which recently unveiled a fully disposable robotic system for endovascular procedures, said it has entered into definitive agreements with certain institutional investors for the sale of 912,858 shares in a registered direct offering at a purchase price of $10.50, priced at-the-market under Nasdaq rules.
• Cassava Sciences, Inc. SAVA fell 14.5% to $3.89 after surging 26.74% on Tuesday.
• PhaseBio Pharmaceuticals, Inc. PHAS shares declined 11.7% to $6.49 after surging 12.3% on Tuesday.
• Harpoon Therapeutics, Inc. HARP fell 10.1% to $18.51.
• Seadrill Limited SDRL shares declined 9.5% to $2.49.
• CLPS Incorporation CLPS dropped 9.4% to $5.80 after climbing 46.1% on Tuesday.
• TravelCenters of America Inc. TA dipped 9% to $17.11.
• Stealth BioTherapeutics Corp MITO tumbled 7.2% to $3.75.
• Repro Med Systems, Inc. KRMD dropped 6.7% to $5.90.
• NIO Limited NIO fell 5.5% to $2.39 after dropping 5.24% on Tuesday. NIO will report Q3 earnings next week on Monday, Dec. 30, 2019 before the market opens.